D P Fairlie Selected Research

phenylalanyl(ornithinyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)

9/2000

Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D P Fairlie Research Topics

Disease

6	Inflammation (Inflammations) 01/2017 - 12/2001
6	Neoplasms (Cancer) 01/2017 - 02/2000
3	Infections 01/2017 - 01/2008
3	Dengue (Dengue Fever) 11/2016 - 12/2001
3	Necrosis 12/2011 - 09/2000
2	Periodontitis 01/2017 - 06/2009
2	Alveolar Bone Loss 12/2011 - 06/2009
2	Bone Resorption 12/2011 - 06/2009
2	Malaria 04/2008 - 05/2000
2	Arthus Reaction 12/2001 - 06/2000
2	Neutropenia 09/2000 - 06/2000
1	Rheumatoid Arthritis 01/2017
1	Bone Diseases (Bone Disease) 01/2017
1	Coinfection 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Hyperalgesia 01/2016
1	Pain (Aches) 01/2016
1	West Nile Fever 01/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2007
1	Melanoma (Melanoma, Malignant) 03/2006
1	Septic Shock (Toxic Shock Syndrome) 09/2000
1	Sepsis (Septicemia) 06/2000
1	Shock 06/2000
1	Immune Complex Diseases (Immune Complex Disease) 06/2000
1	Virus Diseases (Viral Diseases) 04/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2000
1	Alzheimer Disease (Alzheimer's Disease) 04/2000

Drug/Important Bio-Agent (IBA)

5	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 04/2000
4	Histone Deacetylase InhibitorsIBA 01/2017 - 06/2000
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2001 - 06/2000
2	PAR-2 ReceptorIBA 01/2017 - 09/2014
2	EnzymesIBA 01/2017 - 04/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 01/2007
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2008 - 03/2006
2	Peptides (Polypeptides)IBA 01/2007 - 12/2001
2	Anaphylatoxin C5a ReceptorIBA 12/2001 - 06/2000
2	Interleukin-6 (Interleukin 6)IBA 12/2001 - 09/2000
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2001 - 06/2000
2	CytokinesIBA 09/2000 - 06/2000
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Toll-Like Receptor AgonistsIBA 01/2017
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2017
1	AntigensIBA 01/2017
1	IsoenzymesIBA 01/2017
1	TrypsinIBA 01/2016
1	Capsaicin (Zostrix)FDA Link 01/2016
1	Pancreatic Elastase (Elastase)IBA 01/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2011
1	Calcitonin Receptors (Calcitonin Receptor)IBA 12/2011
1	Messenger RNA (mRNA)IBA 12/2011
1	N8- hydroxy- 2- (1H- indole- 2- carboxamido)- N1- (quinolin- 8- yl)octanediamideIBA 12/2011
1	InterferonsIBA 12/2011
1	PLIalphaIBA 06/2009
1	Secretory Phospholipases A2IBA 06/2009
1	Antimalarials (Antimalarial Agents)IBA 04/2008
1	Antiviral Agents (Antivirals)IBA 01/2008
1	VaccinesIBA 01/2008
1	SaltsIBA 01/2007
1	Amino Acids FDA Link 01/2007
1	Basic Amino Acids (Basic Amino Acid)IBA 01/2007
1	PolyproteinsIBA 01/2007
1	FurinIBA 01/2007
1	PrionsIBA 01/2007
1	Amyloid (Amyloid Fibrils)IBA 01/2007
1	AminesIBA 03/2006
1	Cysteine (L-Cysteine)FDA Link 03/2006
1	LigandsIBA 03/2006
1	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 12/2001
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2001
1	cyclohexylalanineIBA 12/2001
1	LipopolysaccharidesIBA 09/2000
1	phenylalanyl(ornithinyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA 09/2000
1	Cyclic PeptidesIBA 09/2000
1	azelaic bishydroxamic acidIBA 06/2000
1	suberic acidIBA 05/2000
1	Cytostatic AgentsIBA 05/2000

Therapy/Procedure

2	Therapeutics 11/2016 - 02/2000
1	Topical Administration 12/2001
1	Oral Administration 12/2001